YPrime’s Karl McEvoy Appointed as eCOA Consortium Industry Co-Director for 2025
January 14, 2025 08:00 ET
|
Y-Prime, LLC
YPrime's Dr. Karl McEvoy, VP eCOA & Patient Technologies, has been appointed Industry Co-Director of the Critical Path Institute (C-Path) eCOA Consortium
YPrime schließt sich dem Global Compact der Vereinten Nationen an und verpflichtet sich, seine nachhaltigen Geschäftspraktiken den UN-Zielen anzupassen
December 17, 2024 09:58 ET
|
Y-Prime, LLC
MALVERN, Pennsylvania, Dec. 17, 2024 (GLOBE NEWSWIRE) -- YPrime der führende Pionier in der Technologie klinischer Studien, hat heute sein formelles Engagement der Vereinten Nationen (UN) Global...
YPrime s’engage à respecter le Pacte mondial des Nations Unies et à aligner ses pratiques commerciales durables sur les objectifs de l’ONU
December 17, 2024 09:58 ET
|
Y-Prime, LLC
MALVERN, Pennsylvanie, 17 déc. 2024 (GLOBE NEWSWIRE) -- YPrime, entreprise pionnière de la technologie des essais cliniques, a annoncé aujourd’hui son engagement formel à respecter le Pacte...
YPrime Commits to United Nations Global Compact, Pledging to Align its Sustainable Business Practices with UN Goals
December 17, 2024 09:57 ET
|
Y-Prime, LLC
YPrime pledges to United Nations Global Compact, expanding its program of sustainable business practices.
YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
September 25, 2024 09:00 ET
|
Y-Prime, LLC
YPrime releases report on site technology experiences, offering sponsors insights to improve trial efficiency by aligning eCOA platforms with user needs.
YPrime Recognized as Trailblazer in Patient Engagement by Everest Group
September 24, 2024 08:42 ET
|
Y-Prime, LLC
YPrime has been recognized as a Trailblazer in patient engagement by Everest Group for its innovative solutions that enhance clinical trial participation.
YPrime bringt bahnbrechende eCOA-Plattform zur Beschleunigung von Implementierungen um bis zu 30 % auf den Markt
July 24, 2024 22:46 ET
|
Y-Prime, LLC
MALVERN, Pennsylvania, July 25, 2024 (GLOBE NEWSWIRE) -- YPrime, der führende Pionier im Bereich der Technologie für klinische Studien, gab heute die Einführung seiner hochmodernen SaaS-Plattform...
YPrime lance sa plateforme eCOA révolutionnaire qui accélérera de 30 % les mises en œuvre
July 24, 2024 22:46 ET
|
Y-Prime, LLC
MALVERN, Pennsylvanie, 25 juill. 2024 (GLOBE NEWSWIRE) -- YPrime, pionnière dans le domaine des technologies pour les essais cliniques, a annoncé aujourd'hui le lancement de sa plateforme SaaS eCOA...
YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
July 24, 2024 09:00 ET
|
Y-Prime, LLC
YPrime releases groundbreaking eCOA platform to revolutionize the clinical trial landscape.
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
June 25, 2024 08:00 ET
|
Y-Prime, LLC
New YPrime research report sheds light on how technology can help solve challenges in endocrinology clinical trials.